• Ekaterina Sorkina and Valentina Chichkova.
• Endocrinology Research Centre, 11, ulitsa Dmitriya Ulianova, Moscow 117036, Russia. Electronic address: sorkina@bk.ru.
• Presse Med. 2021 Nov 1; 50 (3): 104075.

AbstractGeneralized lipodystrophy (GL) syndromes are a group of rare heterogenous disorders, characterized by total subcutaneous fat loss. The frequency of GL is currently assessed as approximately 0,23 cases per million of the population, in Europe - as 0,96 cases per million of the population. They can be congenital (CGL) or acquired (AGL) depending on the etiology and the time of the onset of fat loss. Both CGL and AGL are often associated with different metabolic complications, such as hypertriglyceridemia, insulin resistance and lipoatrophic diabetes mellitus, metabolically associated FLD, arterial hypertension, proteinuria, reproductive system disorders. In this review we aimed to summarize the information on all forms of generalized lipodystrophy, especially the ones of genetic etiology, their clinical manifestations and complications, the perspectives for diagnostics, treatment and further research.Copyright © 2021 Elsevier Masson SAS. All rights reserved.

55 keywords...

hide…